Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset

CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in non-obese diabetic (NOD) mice....

Descripción completa

Detalles Bibliográficos
Autores: Alonso, Nuria, Julián, María Teresa, Carrascal, Jorge, Colobran, Roger, Pujol-Autonell, Irma, Teniente, Aina, Fernández, Marco Antonio, Miñarro Alonso, Antonio, María Ruiz de Villa, Carmen, Vives-Pi, Marta, Puig Domingo, Manuel, Rodriguez-Fernández, Silvia
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/68549
Acceso en línea:https://hdl.handle.net/2445/68549
Access Level:acceso abierto
Palabra clave:Diabetis
Limfòcits
Citologia
Ratolins (Animals de laboratori)
Diabetes
Lymphocytes
Cytology
Mice (Laboratory animals)
id ES_44574f9c8a0d0329a8c24e2b39de08ea
oai_identifier_str oai:recercat.cat:2445/68549
network_acronym_str ES
network_name_str España
repository_id_str
spelling Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subsetAlonso, NuriaJulián, María TeresaCarrascal, JorgeColobran, RogerPujol-Autonell, IrmaTeniente, AinaFernández, Marco AntonioMiñarro Alonso, AntonioMaría Ruiz de Villa, CarmenVives-Pi, MartaPuig Domingo, ManuelRodriguez-Fernández, SilviaDiabetisLimfòcitsCitologiaRatolins (Animals de laboratori)DiabetesLymphocytesCytologyMice (Laboratory animals)CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in non-obese diabetic (NOD) mice. The aim of the present study was to assess the effect of MK626, a DPPIV inhibitor, in type 1 diabetes incidence and in T lymphocyte subsets at central and peripheral compartments. Pre-diabetic NOD mice were treated with MK626. Diabetes incidence, insulitis score, and phenotyping of T lymphocytes in the thymus, spleen and pancreatic lymph nodes were determined after 4 and 6 weeks of treatment, as well as alterations in the expression of genes encoding β-cell autoantigens in the islets. The effect of MK626 was also assessed in two in vitro assays to determine proliferative and immunosuppressive effects. Results show that MK626 treatment reduces type 1 diabetes incidence and after 6 weeks of treatment reduces insulitis. No differences were observed in the percentage of T lymphocyte subsets from central and peripheral compartments between treated and control mice. MK626 increased the expression of CD26 in CD8+ T effector memory (TEM) from spleen and pancreatic lymph nodes and in CD8+ T cells from islet infiltration. CD8+TEM cells showed an increased proliferation rate and cytokine secretion in the presence of MK626. Moreover, the combination of CD8+ TEM cells and MK626 induces an immunosuppressive response. In conclusion, treatment with the DPPIV inhibitor MK626 prevents experimental type 1 diabetes in association to increase expression of CD26 in the CD8+ TEM lymphocyte subset. In vitro assays suggest an immunoregulatory role of CD8+ TEM cells that may be involved in the protection against autoimmunity to β pancreatic islets associated to DPPIV inhibitor treatment.Public Library of Science (PLoS)2015201520152015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion22 p.application/pdfhttps://hdl.handle.net/2445/68549Articles publicats en revistes (Genètica, Microbiologia i Estadística)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0142186PLoS One, 2015, vol. 10, num. 11, p. e0142186-e0142186http://dx.doi.org/10.1371/journal.pone.0142186cc-by (c) Alonso, Nuria et al., 2015http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/685492026-05-29T05:05:01Z
dc.title.none.fl_str_mv Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
title Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
spellingShingle Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
Alonso, Nuria
Diabetis
Limfòcits
Citologia
Ratolins (Animals de laboratori)
Diabetes
Lymphocytes
Cytology
Mice (Laboratory animals)
title_short Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
title_full Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
title_fullStr Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
title_full_unstemmed Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
title_sort Type1 Diabetes prevention in NOD mice by targeting DPPIV/CD26 is associated with changes in CD8+T effector memory subset
dc.creator.none.fl_str_mv Alonso, Nuria
Julián, María Teresa
Carrascal, Jorge
Colobran, Roger
Pujol-Autonell, Irma
Teniente, Aina
Fernández, Marco Antonio
Miñarro Alonso, Antonio
María Ruiz de Villa, Carmen
Vives-Pi, Marta
Puig Domingo, Manuel
Rodriguez-Fernández, Silvia
author Alonso, Nuria
author_facet Alonso, Nuria
Julián, María Teresa
Carrascal, Jorge
Colobran, Roger
Pujol-Autonell, Irma
Teniente, Aina
Fernández, Marco Antonio
Miñarro Alonso, Antonio
María Ruiz de Villa, Carmen
Vives-Pi, Marta
Puig Domingo, Manuel
Rodriguez-Fernández, Silvia
author_role author
author2 Julián, María Teresa
Carrascal, Jorge
Colobran, Roger
Pujol-Autonell, Irma
Teniente, Aina
Fernández, Marco Antonio
Miñarro Alonso, Antonio
María Ruiz de Villa, Carmen
Vives-Pi, Marta
Puig Domingo, Manuel
Rodriguez-Fernández, Silvia
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Diabetis
Limfòcits
Citologia
Ratolins (Animals de laboratori)
Diabetes
Lymphocytes
Cytology
Mice (Laboratory animals)
topic Diabetis
Limfòcits
Citologia
Ratolins (Animals de laboratori)
Diabetes
Lymphocytes
Cytology
Mice (Laboratory animals)
description CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in non-obese diabetic (NOD) mice. The aim of the present study was to assess the effect of MK626, a DPPIV inhibitor, in type 1 diabetes incidence and in T lymphocyte subsets at central and peripheral compartments. Pre-diabetic NOD mice were treated with MK626. Diabetes incidence, insulitis score, and phenotyping of T lymphocytes in the thymus, spleen and pancreatic lymph nodes were determined after 4 and 6 weeks of treatment, as well as alterations in the expression of genes encoding β-cell autoantigens in the islets. The effect of MK626 was also assessed in two in vitro assays to determine proliferative and immunosuppressive effects. Results show that MK626 treatment reduces type 1 diabetes incidence and after 6 weeks of treatment reduces insulitis. No differences were observed in the percentage of T lymphocyte subsets from central and peripheral compartments between treated and control mice. MK626 increased the expression of CD26 in CD8+ T effector memory (TEM) from spleen and pancreatic lymph nodes and in CD8+ T cells from islet infiltration. CD8+TEM cells showed an increased proliferation rate and cytokine secretion in the presence of MK626. Moreover, the combination of CD8+ TEM cells and MK626 induces an immunosuppressive response. In conclusion, treatment with the DPPIV inhibitor MK626 prevents experimental type 1 diabetes in association to increase expression of CD26 in the CD8+ TEM lymphocyte subset. In vitro assays suggest an immunoregulatory role of CD8+ TEM cells that may be involved in the protection against autoimmunity to β pancreatic islets associated to DPPIV inhibitor treatment.
publishDate 2015
dc.date.none.fl_str_mv 2015
2015
2015
2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/68549
url https://hdl.handle.net/2445/68549
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0142186
PLoS One, 2015, vol. 10, num. 11, p. e0142186-e0142186
http://dx.doi.org/10.1371/journal.pone.0142186
dc.rights.none.fl_str_mv cc-by (c) Alonso, Nuria et al., 2015
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Alonso, Nuria et al., 2015
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 22 p.
application/pdf
dc.publisher.none.fl_str_mv Public Library of Science (PLoS)
publisher.none.fl_str_mv Public Library of Science (PLoS)
dc.source.none.fl_str_mv Articles publicats en revistes (Genètica, Microbiologia i Estadística)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407086072299520
score 15,811543